Nonclinical Safety Evaluation of Nonmutagenic Immunogrit Following Subacute 28‐Day Repeated Dose Oral Toxicity in Sprague–Dawley Rats With GLP Compliance
Journal of Toxicology · 2026-01 · 2026 (1)
DOI: 10.1155/jt/2786338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Toxicology, online erschienen am 18.07.2026. Verfasst von Acharya Balkrishna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar 249 405, Uttarakhand, India, patanjaliresearchfoundation.com. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunogrit is a traditional Ayurvedic medicine prescribed to patients for their general well‐being. In this study, Immunogrit was evaluated for its subacute (28 days) repeated oral dose toxicity in male and female Sprague‐Dawley (SD) rats of similar age and body weight following OECD 407 guidelines under Good Laboratory Practices compliance. Mutagenic potential of Immunogrit was also evaluated through Ames assay following OECD 471 guidelines. Phytochemical profiling of the Immunogrit was performed using ultraperformance liquid chromatography coupled with electrospray ionization quadrupole time‐of‐flight(UPLC/MS‐QToF) tandem mass spectrometer. UPLC/MS‐QToF analysis of Immunogrit identified 74 phytochemicals, well known for their health benefits. Male and female specific pathogen–free SD rats were orally gavaged to 100, 300, and 1000 mg/kg body weight/day of Immunogrit, over a period of 28 days, with two additional groups for a recovery phase of 14 days. No incidence of mortality, morbidity, or abnormal clinical signs was observed in the Immunogrit‐exposed animals. Body weight, behavioral, and food consumption habit were found to be normal throughout the study period. Immunogrit exposure did not induce ophthalmic, neurological, functional, hematological, biochemical, and histopathological irregularities in animals over a period of 28 days. Latent incidence of toxicity was also not observed in the recovery group male and female rats kept under observation for an additional 14 days’ post‐Immunogrit exposure. Ames test of Immunogrit and its S9‐treated fraction in Salmonella typhimurium strains TA1535, TA1537, TA98, and TA100, and Escherichia coli WP2uvrA did not show any induced mutagenic potential, up to the highest dose tested. In conclusion, Immunogrit was found to be nonmutagenic and showed a “no‐observed‐adverse‐effect‐level” (NOAEL) of 1000 mg/kg body weight/day in male and female SD rats.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar 249 405, Uttarakhand, India, patanjaliresearchfoundation.com.
- Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Haridwar 249 405, Uttarakhand, India, universityofpatanjali.com.
- Patanjali Yog Peeth (UK) Trust, 40 Lambhill Street Kinning Park, Glasgow G41 1AU, UK.
ORCID-Profile: Kunal Bhattacharya, Anurag Varshney
Zitieren
APA
Balkrishna, A., Bhattacharya, K., Verma, S., Jangid, H., Lochab, S., & Varshney, A. (2026). Nonclinical Safety Evaluation of Nonmutagenic Immunogrit Following Subacute 28‐Day Repeated Dose Oral Toxicity in Sprague–Dawley Rats With GLP Compliance. Journal of Toxicology, 2026(1). https://doi.org/10.1155/jt/2786338
Vancouver
Balkrishna A, Bhattacharya K, Verma S, Jangid H, Lochab S, Varshney A. Nonclinical Safety Evaluation of Nonmutagenic Immunogrit Following Subacute 28‐Day Repeated Dose Oral Toxicity in Sprague–Dawley Rats With GLP Compliance. Journal of Toxicology. 2026;2026(1). doi:10.1155/jt/2786338
BibTeX
@article{Balkrishna2026,
author = {Balkrishna, Acharya and Bhattacharya, Kunal and Verma, Sudeep and Jangid, Himanshu and Lochab, Savita and Varshney, Anurag},
title = {Nonclinical Safety Evaluation of Nonmutagenic Immunogrit Following Subacute 28‐Day Repeated Dose Oral Toxicity in Sprague–Dawley Rats With GLP Compliance},
journal = {Journal of Toxicology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jt/2786338}
}
EUVIMED